Lukasz is a scientist with a strong focus on research applicability. He would like to help the most brilliant inventions to change the world as soon as possible!

During his student times, Lukasz was one of the founders of Oxbridge Biotech Roundtable, where he helped with organizing events and consulting projects. It was then where he developed passion for grassroot organizations, which eventually led him to Innovation Forum.
His research career started at University of Edinburgh with a BSc in Biotechnology followed by a PhD in Biotechnology at Cambridge, UK. His biological experience oscillates around synthetic biology, omics studies and clean power generation.

His previous leadership projects include proof-of-concept work with biofuel distillery waste and a scientific expedition to lake Baikal, Siberia.

Dr. Massimo Merighi is associate head of metabolic engineering at Ginkgo Bioworks (Boston, MA, USA). Before joining Ginkgo, he worked at Glycosyn (Woburn, MA, USA) on the metabolic engineering of Escherichia coli to produce human milk oligosaccharides (HMO). An organism he engineered capable of 2' fucosyllactose biosynthesis has reached production scale and commercialization as a food ingredient for baby formula by a major manufacturer. Dr. Merighi trained at Harvard University (Department of Microbiology and Molecular Genetics) and Ohio State University (Center for Microbial Interface Biology; Department of Plant Pathology), where he obtained his PhD in 2003. His undergraduate studies in Agricultural Engineering were completed in Italy at the University of Bologna. He holds a number of patents on the metabolic engineering of HMOs and he is the author of 66 papers, reviews, book chapters, and patent applications. He has served as reviewer for the U.S. National Science Foundation, NIFA, the U.S. Department of Agriculture, and the journal Molecular Microbiology. He is currently associate editor for Frontiers in Cellular and Infection Microbiology.